FDA Approvals and Earnings Beats Propel Specialized US-Listed FirmsGlobal Report·1 day ago, 04:14 AMREPL-11.03%CELC-0.42%
The 'Everything Else' Trade: 10 Outliers Defining the 2026 MarketGlobal Report·2 days ago, 04:14 AMAPPS+1.66%IBN+1.29%
The Value Chain Dictates the Outcome: From Defense Platforms to Biotech AggregatorsGlobal Report·Jul 21 at 04:13 AMSMJF+0.18%LHX+1.09%
3 US Growth Stocks Analysts Expect To Benefit From AI Infrastructure DemandSimplywall·Jul 18 at 08:05 PMRELY+0.58%CELC-0.42%
Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Datarttnews·Jul 18 at 12:22 AMCELC-0.42%MRK-0.24%
Celcuity plunges 16% as breast cancer drug launch delayed to Q3US Stock Market Update·Jul 15 at 01:01 PMCELC-0.42%
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double DigitsUnusual Whales·Jul 15 at 10:41 AMCELC-0.42%
Celcuity plunges nearly 17% as breast cancer drug launch delayedUS Stock Market Update·Jul 15 at 08:52 AMCELC-0.42%
CrowdStrike To Rally Over 12%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga_article·Jul 15 at 08:06 AMAMBP+1.26%CRWD-1.73%
